CL2014003242A1 - Compuestos de pirazol sustituidos como antagonistas del receptor del acido lisofosfatidico (lpar); usos contra la fibrosis pulmonar. - Google Patents
Compuestos de pirazol sustituidos como antagonistas del receptor del acido lisofosfatidico (lpar); usos contra la fibrosis pulmonar.Info
- Publication number
- CL2014003242A1 CL2014003242A1 CL2014003242A CL2014003242A CL2014003242A1 CL 2014003242 A1 CL2014003242 A1 CL 2014003242A1 CL 2014003242 A CL2014003242 A CL 2014003242A CL 2014003242 A CL2014003242 A CL 2014003242A CL 2014003242 A1 CL2014003242 A1 CL 2014003242A1
- Authority
- CL
- Chile
- Prior art keywords
- lpar
- receptor antagonists
- pulmonary fibrosis
- acid receptor
- lysophosphatidic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261661958P | 2012-06-20 | 2012-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014003242A1 true CL2014003242A1 (es) | 2015-03-20 |
Family
ID=48656033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014003242A CL2014003242A1 (es) | 2012-06-20 | 2014-11-28 | Compuestos de pirazol sustituidos como antagonistas del receptor del acido lisofosfatidico (lpar); usos contra la fibrosis pulmonar. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20150259295A1 (pt-PT) |
| EP (1) | EP2864294A1 (pt-PT) |
| JP (1) | JP2015520201A (pt-PT) |
| KR (1) | KR20150011003A (pt-PT) |
| CN (1) | CN104411690A (pt-PT) |
| AU (1) | AU2013279510A1 (pt-PT) |
| BR (1) | BR112014031108A2 (pt-PT) |
| CA (1) | CA2869602A1 (pt-PT) |
| CL (1) | CL2014003242A1 (pt-PT) |
| CO (1) | CO7160077A2 (pt-PT) |
| CR (1) | CR20140516A (pt-PT) |
| EA (1) | EA201492283A1 (pt-PT) |
| HK (1) | HK1206341A1 (pt-PT) |
| IL (1) | IL236091A0 (pt-PT) |
| IN (1) | IN2014DN09347A (pt-PT) |
| MA (1) | MA37765A1 (pt-PT) |
| MX (1) | MX2014014105A (pt-PT) |
| PE (1) | PE20142445A1 (pt-PT) |
| PH (1) | PH12014502364A1 (pt-PT) |
| SG (1) | SG11201407229UA (pt-PT) |
| UA (1) | UA109867C2 (pt-PT) |
| WO (1) | WO2013189862A1 (pt-PT) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8975235B2 (en) | 2011-03-20 | 2015-03-10 | Intermune, Inc. | Lysophosphatidic acid receptor antagonists |
| US10000459B2 (en) | 2013-03-15 | 2018-06-19 | Epigen Biosciences, Inc. | Heterocyclic compounds useful in the treatment of disease |
| RU2689315C2 (ru) | 2014-06-27 | 2019-05-27 | Убе Индастриз, Лтд. | Соль гетероциклического соединения, замещенного галогеном |
| KR20200100712A (ko) * | 2017-12-19 | 2020-08-26 | 브리스톨-마이어스 스큅 컴퍼니 | Lpa 길항제로서의 피라졸 n-연결된 카르바모일 시클로헥실 산 |
| CN111434655A (zh) * | 2019-01-15 | 2020-07-21 | 武汉朗来科技发展有限公司 | 溶血磷脂酸受体拮抗剂及其制备方法 |
| JP7431961B2 (ja) | 2019-11-15 | 2024-02-15 | ギリアード サイエンシーズ， インコーポレイテッド | Ｌｐａ受容体アンタゴニストとしてのトリアゾールカルバメートピリジルスルホンアミド及びその使用 |
| KR20230019880A (ko) | 2020-06-03 | 2023-02-09 | 길리애드 사이언시즈, 인코포레이티드 | Lpa 수용체 길항제 및 이의 용도 |
| AU2021285747A1 (en) | 2020-06-03 | 2023-01-19 | Gilead Sciences, Inc. | LPA receptor antagonists and uses thereof |
| TW202400561A (zh) * | 2021-05-11 | 2024-01-01 | 美商基利科學股份有限公司 | Lpa受體拮抗劑及其用途 |
| US11939318B2 (en) | 2021-12-08 | 2024-03-26 | Gilead Sciences, Inc. | LPA receptor antagonists and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2005063241A1 (ja) * | 2003-12-26 | 2007-07-19 | 小野薬品工業株式会社 | ミトコンドリアベンゾジアゼピン受容体介在性疾患の予防および／または治療剤 |
| TW200827346A (en) | 2006-11-03 | 2008-07-01 | Astrazeneca Ab | Chemical compounds |
| US20090036425A1 (en) | 2007-08-02 | 2009-02-05 | Pfizer Inc | Substituted bicyclolactam compounds |
| GB2466121B (en) * | 2008-12-15 | 2010-12-08 | Amira Pharmaceuticals Inc | Antagonists of lysophosphatidic acid receptors |
| GB2470833B (en) * | 2009-06-03 | 2011-06-01 | Amira Pharmaceuticals Inc | Polycyclic antagonists of lysophosphatidic acid receptors |
| WO2011017350A2 (en) * | 2009-08-04 | 2011-02-10 | Amira Pharmaceuticals, Inc. | Compounds as lysophosphatidic acid receptor antagonists |
| BR112013014019A2 (pt) * | 2010-12-07 | 2016-09-13 | Amira Pharmaceuticals Inc | antagonistas do receptor do ácido lisofosfatídico e seus usos |
| US8975235B2 (en) * | 2011-03-20 | 2015-03-10 | Intermune, Inc. | Lysophosphatidic acid receptor antagonists |
| WO2012138648A1 (en) * | 2011-04-06 | 2012-10-11 | Irm Llc | Compositions and methods for modulating lpa receptors |
-
2013
- 2013-06-17 AU AU2013279510A patent/AU2013279510A1/en not_active Abandoned
- 2013-06-17 UA UAA201500427A patent/UA109867C2/ru unknown
- 2013-06-17 IN IN9347DEN2014 patent/IN2014DN09347A/en unknown
- 2013-06-17 EA EA201492283A patent/EA201492283A1/ru unknown
- 2013-06-17 PE PE2014002212A patent/PE20142445A1/es not_active Application Discontinuation
- 2013-06-17 EP EP13729940.0A patent/EP2864294A1/en not_active Withdrawn
- 2013-06-17 US US14/402,128 patent/US20150259295A1/en not_active Abandoned
- 2013-06-17 JP JP2015517702A patent/JP2015520201A/ja active Pending
- 2013-06-17 BR BR112014031108A patent/BR112014031108A2/pt not_active Application Discontinuation
- 2013-06-17 MX MX2014014105A patent/MX2014014105A/es unknown
- 2013-06-17 CN CN201380032266.8A patent/CN104411690A/zh active Pending
- 2013-06-17 SG SG11201407229UA patent/SG11201407229UA/en unknown
- 2013-06-17 WO PCT/EP2013/062458 patent/WO2013189862A1/en active Application Filing
- 2013-06-17 KR KR1020147035552A patent/KR20150011003A/ko not_active Application Discontinuation
- 2013-06-17 CA CA2869602A patent/CA2869602A1/en not_active Abandoned
- 2013-06-17 MA MA37765A patent/MA37765A1/fr unknown
-
2014
- 2014-10-22 PH PH12014502364A patent/PH12014502364A1/en unknown
- 2014-11-11 CR CR20140516A patent/CR20140516A/es unknown
- 2014-11-28 CL CL2014003242A patent/CL2014003242A1/es unknown
- 2014-12-04 IL IL236091A patent/IL236091A0/en unknown
- 2014-12-19 CO CO14279332A patent/CO7160077A2/es unknown
-
2015
- 2015-07-21 HK HK15106926.9A patent/HK1206341A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201407229UA (en) | 2014-12-30 |
| US20150259295A1 (en) | 2015-09-17 |
| MX2014014105A (es) | 2015-03-05 |
| IL236091A0 (en) | 2015-02-01 |
| KR20150011003A (ko) | 2015-01-29 |
| EP2864294A1 (en) | 2015-04-29 |
| PH12014502364A1 (en) | 2015-01-12 |
| JP2015520201A (ja) | 2015-07-16 |
| EA201492283A1 (ru) | 2015-04-30 |
| BR112014031108A2 (pt) | 2017-06-27 |
| CA2869602A1 (en) | 2013-12-27 |
| PE20142445A1 (es) | 2015-01-28 |
| CO7160077A2 (es) | 2015-01-15 |
| UA109867C2 (ru) | 2015-10-12 |
| IN2014DN09347A (pt-PT) | 2015-07-17 |
| AU2013279510A1 (en) | 2014-10-16 |
| WO2013189862A1 (en) | 2013-12-27 |
| HK1206341A1 (en) | 2016-01-08 |
| CN104411690A (zh) | 2015-03-11 |
| MA37765A1 (fr) | 2017-04-28 |
| CR20140516A (es) | 2014-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2014003243A1 (es) | Compuestos de n-alquiltriazol como antagonistas del receptor del acido lisofosfatidico (lpar); usos contra fibrosis pulmonar. | |
| CL2014003241A1 (es) | Compuestos de n-ariltriazol como antagonistas del receptor de acido lisofosfatidico (lpar); y su uso contra la fibrosis pulmonar. | |
| CL2014003242A1 (es) | Compuestos de pirazol sustituidos como antagonistas del receptor del acido lisofosfatidico (lpar); usos contra la fibrosis pulmonar. | |
| IL277652B (en) | Stable aqueous formulations of adlimumab | |
| HK1199259A1 (en) | Lysophosphatidic acid receptor antagonists | |
| EP2890691A4 (en) | BENZIMIDAZOLE DERIVATIVES AS ITK INHIBITORS | |
| HK1252945A1 (zh) | 次氯酸水溶液 | |
| CO6970595A2 (es) | Nuevos 2h-indazoles como antagonistas del receptor ep2 | |
| CL2015001399A1 (es) | Composiciones detergentes acuosas de estructura polimérica. | |
| SI2928882T1 (sl) | Pirazinski derivati kot agonisti receptorja CB2 | |
| HK1207633A1 (en) | Benzimidazol.es as cns active agents cns | |
| CO7010832A2 (es) | Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina | |
| HK1225712A1 (zh) | 作爲溶血磷脂酸受體拮抗劑的酰胺衍生物 | |
| CO6801731A2 (es) | Compuesto de pirazol como antagonistas de crth2 | |
| PL2836580T3 (pl) | Mikrofibrylarna celuloza jako substancja czynna zdolna do odrywania brudu | |
| ZA201500979B (en) | Electrochemical generation of chlorinated urea derivatives | |
| EP2887939A4 (en) | BENZOIC ACID DERIVATIVES SPECIFIC TO LPA2 RECEPTOR | |
| FR2989199B1 (fr) | Adaptateur electriquement actif | |
| GB2532070B (en) | Improvements relating to hypochlorous acid solutions | |
| FR2989095B1 (fr) | Clem2, retrotransposon actif des cafeiers | |
| ZA201505378B (en) | Formulations of 3-(6-(1-(2.2-diflourobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin--2-yl)benzoic acid | |
| FI20125274A (fi) | Levuliinihapon valmistus |